1. Antiretroviral regimens in pregnancy and breast-feeding in Botswana
- Author
-
Shapiro, R.L., Snowden, W., Martinez-Tristani, M., Mazhani, L., Essex, M., Souda, S., Lubega, E., Akhtar, M., Wester, C., Tuomola, R., Sharma, U., Handelsman, E., Mburu, K., Jayeoba, O., Moko, E., Leidner, J., Powis, K., Asmelash, A., Tumbare, E., Zwerski, S., Makhema, J., Moyo, S., Thior, I., McIntosh, K., van Widenfelt, E., Hughes, M.D., Ogwu, A., Kitch, D., Lockman, S., and Moffat, C.
- Subjects
Highly active antiretroviral therapy -- Health aspects ,HIV infection -- Drug therapy ,HIV infection -- Prevention ,Disease transmission -- Risk factors ,Disease transmission -- Patient outcomes ,Pregnancy -- Health aspects ,Breast feeding -- Health aspects ,HIV infection in pregnancy -- Drug therapy ,HIV infection in pregnancy -- Prevention - Abstract
The study attempts to evaluate the most effective and safe highly active antiretroviral therapy (HAART) in preventing human immunedeficiency virus type -1 (HIV-1) transmission during pregnancy and breast-feeding. The results indicate that all regimes of HAART had positive outcomes in reducing HIV-1 transmission, with a overall rate of 1.1% between mother and infant.
- Published
- 2010